Our study provides the first experimental evidence that OT attenuates neuroinflammation in a VPA-induced autism rat model by modulating the microbiota-gut-brain axis through inhibition of TLR-4/IκB-α/NF-κB signaling pathway. Here, NFKB1 is linked to autism.